文献速递复苏、休克与脓毒症心脑血管急症重症综合管理与镇静镇痛

血清乳酸及其相对变化对心源性休克患者死亡率的预测——CardShock研究结果

Serum Lactate and A Relative Change in Lactate as Predictors of Mortality in Patients With Cardiogenic Shock - Results from the Cardshock Study.
PubMed 文献 · Shock · 2020-01-01
一句话结论心源性休克患者入院基线乳酸及6、12、24小时乳酸和乳酸相对下降幅度均可预测30天死亡率,24小时内乳酸相对变化提供基线值之外的预后信息。

这是CardShock研究的二次分析,纳入219例心源性休克患者,其中217例有基线乳酸数据。基线乳酸中位数2.8 mmol/L(最小-最大范围0.5-23.1 mmol/L)。入院时乳酸预测30天死亡率,校正后HR为1.20 mmol/L(95%CI 1.14-1.27)。入院24小时内基线乳酸仍具预测性;6小时乳酸HR 1.14(95%CI 1.06-1.24),12小时HR 1.10(95%CI 1.04-1.17),24小时HR 1.19(95%CI 1.07-1.32)。6小时内乳酸下降50%对应HR 0.82(95%CI 0.72-0.94),12小时HR 0.87(95%CI 0.76-0.98),24小时HR 0.74(95%CI 0.60-0.91)。结论:基线乳酸是30天死亡率的强预测因子,6、12、24小时乳酸可预测30天死亡率,乳酸相对变化是重症治疗启动后24小时内生存的显著预测因子,提供基线值之外的额外信息。

要点

  • 心源性休克患者入院基线乳酸中位数2.8 mmol/L(范围0.5-23.1 mmol/L),基线乳酸预测30天死亡率校正HR 1.20 mmol/L(95%CI 1.14-1.27)。
  • 入院后6小时乳酸HR 1.14(95%CI 1.06-1.24)、12小时HR 1.10(95%CI 1.04-1.17)、24小时HR 1.19(95%CI 1.07-1.32),均为30天死亡率预测因子。
  • 6小时内乳酸下降50%对应30天死亡率HR 0.82(95%CI 0.72-0.94),12小时HR 0.87(95%CI 0.76-0.98),24小时HR 0.74(95%CI 0.60-0.91)。
  • 乳酸相对变化在重症治疗启动后24小时内是生存的显著预测因子,提供基线值之外的额外信息。
  • 该研究为CardShock研究的二次分析,219例患者中217例有基线乳酸数据。

适用人群与场景

  • 急性心肌梗死并发心源性休克的患者,来自CardShock研究,219例中217例有基线乳酸数据。

研究设计与关键结果

  • 研究类型:CardShock研究的二次分析,纳入219例心源性休克患者,217例有基线乳酸数据。
  • 基线乳酸中位数2.8 mmol/L(最小-最大范围0.5-23.1 mmol/L)。
  • 入院时乳酸预测30天死亡率,校正后HR 1.20 mmol/L(95%CI 1.14-1.27)。
  • 入院24小时内基线乳酸仍预测30天死亡率;6小时乳酸HR 1.14(95%CI 1.06-1.24),12小时HR 1.10(95%CI 1.04-1.17),24小时HR 1.19(95%CI 1.07-1.32)。
  • 6小时内乳酸下降50%对应HR 0.82(95%CI 0.72-0.94),12小时HR 0.87(95%CI 0.76-0.98),24小时HR 0.74(95%CI 0.60-0.91)。
  • 结论:基线乳酸是30天死亡率的强预测因子,6、12、24小时乳酸可预测30天死亡率,乳酸相对变化是重症治疗启动后24小时内生存的显著预测因子,提供基线值之外的额外信息。

证据类型、等级与局限

  • 证据类型:CardShock研究的二次分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文结论表明基线乳酸是心源性休克患者30天死亡率的强预测因子,6、12、24小时乳酸及乳酸相对变化可预测30天死亡率,乳酸相对变化在重症治疗启动后24小时内提供基线值之外的额外信息。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: Cardiogenic shock complicating acute myocardial infarction has a very high mortality. Our present study focuses on serial measurement of lactate during admission due to cardiogenic shock and the prognostic effect of lactate and a relative change in lactate in patients after admission and the institution of intensive care treatment.

METHODS AND RESULTS: This is a secondary analysis of the CardShock study. Data on lactate at baseline were available on 217 of 219 patients.In the study population, the median baseline lactate was 2.8 mmol/L (min-max range, 0.5-23.1 mmol/L).At admission, lactate was predictive of 30-day mortality with an adjusted Hazard ratio (HR) of 1.20 mmol/L (95% confidence interval, CI 1.14-1.27). Within the first 24 h of admission, baseline lactate remained predictive of 30-day mortality. Lactate at 6 h had a HR of 1.14 (95% CI 1.06-1.24) and corresponding values at 12 and 24 h had a HR of 1.10 (1.04-1.17), and of HR 1.19 (95% CI 1.07-1.32), respectively. A 50% reduction in lactate within 6 h resulted in a HR of 0.82 (95% CI 0.72-0.94). Corresponding hazard ratios at 12 and 24 h, were 0.87 (95% CI 0.76-0.98) and 0.74 (95% CI 0.60-0.91), respectively.

CONCLUSION: The main findings of the present study are that baseline lactate is a powerful predictor of 30-day mortality, lactate at 6, 12, and 24 h after admission are predictors of 30-day mortality, and a relative change in lactate is a significant predictor of survival within the first 24 h after instituting intensive care treatment adding information beyond the information from baseline values.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Lindholm MG, Hongisto M, Lassus J, et al. Serum Lactate and A Relative Change in Lactate as Predictors of Mortality in Patients With Cardiogenic Shock - Results from the Cardshock Study. Shock. 2020. PMID: 30973460. doi:10.1097/SHK.0000000000001353

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。